Fig. 6

GM-CSF treatment leads to decreased expression of Mertk, Axl and Timd4 on mouse BM EBI macrophages. A Plot of Mertk versus FSC-H of DAPI⁻CD11b⁻Gr1⁻ F4/80⁺macrophages in control and GM-CSF treated mice BM. B Quantitative analysis of Mertk⁺ percentage and the fluorescence intensity of Mertk. C Plot of Axl versus FSC-H of DAPI⁻CD11b⁻Gr1⁻ F4/80⁺macrophages in control and GM-CSF treated mice BM. D Quantitative analysis of Axl⁺ percentage and the fluorescence intensity of Axl. E Plot of Timd4 versus FSC-H of DAPI⁻CD11b⁻Gr1⁻ F4/80⁺macrophages in control and GM-CSF-treated mice BM. F Quantitative analysis of Timd4⁺ percentage and fluorescence intensity of Timd4. G Plot of Ter119 versus FSC-H of CD11b⁻Gr1⁻ F4/80⁺macrophages in control and GM-CSF-treated mice BM. H Quantitative analysis of engulfment of Ter119⁺ Red blood cells of CD11b⁻Gr1⁻ F4/80⁺macrophages in control and GM-CSF treated mice BM. *P < 0.05, ** P < 0.01 *** P < 0.001. N = 3–6